Regulation of neuronal PLCγ by chronic morphine

Brain Research

Volumn 1156, Issue 1, 2007, Pages 9-20

  Wolf, Daniel H ^a   Nestler, Eric J ^a,b   Russell, David S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Herpes simplex virus; Neurotrophin; Opiate; Phospholipase C ; Tyrosine phosphorylation; Ventral tegmental area

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MORPHINE; NALTREXONE; PHOSPHOLIPASE C GAMMA1; NERVE GROWTH FACTOR; PHOSPHOLIPASE C GAMMA; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME REGULATION; HIPPOCAMPUS; MALE; NERVE CELL; NEUROCHEMISTRY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; TISSUE DISTRIBUTION; UPREGULATION; VENTRAL TEGMENTUM; ANIMAL; CELL STRAIN; ENZYMOLOGY; GENE VECTOR; GENETICS; HERPES SIMPLEX VIRUS; KINETICS; LIMBIC SYSTEM; METABOLISM; PHOSPHORYLATION;

RATTUS; SIMPLEXVIRUS;

ANIMALS; CORPUS STRIATUM; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENETIC VECTORS; KINETICS; LIMBIC SYSTEM; MORPHINE; NERVE GROWTH FACTORS; NEURONS; PC12 CELLS; PHOSPHOLIPASE C GAMMA; PHOSPHORYLATION; RATS; RECOMBINANT PROTEINS; SIMPLEXVIRUS;

EID: 34250312780     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.04.059     Document Type: Article

References (93)

1. Akbarian S., Rios M., Liu R.J., Gold S.J., Fong H.F., Zeiler S., Coppola V., Tessarollo L., Jones K.R., Nestler E.J., Aghajanian G.K., and Jaenisch R. Brain-derived neurotrophic factor is essential for opiate-induced plasticity of noradrenergic neurons. J. Neurosci. 22 (2002) 4153-4162
2. Bassa B.V., Roh D.D., Vaziri N.D., Kirschenbaum M.A., and Kamanna V.S. Lysophosphatidylcholine activates mesangial cell PKC and MAP kinase by PLC gamma-1 and tyrosine kinase-Ras pathways. Am. J. Physiol. 277 (1999) F328-F337
3. Beitner-Johnson D., Guitart X., and Nestler E.J. Neurofilament proteins and the mesolimbic dopamine system: common regulation by chronic morphine and chronic cocaine in the rat ventral tegmental area. J. Neurosci. 12 (1992) 2165-2176
4. Beitner-Johnson D., Guitart X., and Nestler E.J. Glial fibrillary acidic protein and the mesolimbic dopamine system: regulation by chronic morphine and Lewis-Fischer strain differences in the rat ventral tegmental area. J. Neurochem. 61 (1993) 1766-1773
5. Berhow M.T., Russell D.S., Terwilliger R.Z., Beitner-Johnson D., Self D.W., Lindsay R.M., and Nestler E.J. Influence of neurotrophic factors on morphine- and cocaine-induced biochemical changes in the mesolimbic dopamine system. Neuroscience 68 (1995) 969-979
6. Berhow M.T., Hiroi N., and Nestler E.J. Regulation of ERK (Extracellular Signal Regulated Kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J. Neurosci. 16 (1996) 4707-4715
7. Berridge M. Inositol trisphophate and calcium signaling. Nature 361 (1993) 315-325
8. Blum S., and Dash P.K. A cell-permeable phospholipase Cgamma1-binding peptide transduces neurons and impairs long-term spatial memory. Learn. Mem. 11 (2004) 239-243
9. Boehm J., Kang M.G., Johnson R.C., Esteban J., Huganir R.L., and Malinow R. Synaptic incorporation of AMPA receptors during LTP is controlled by a PKC phosphorylation site on GluR1. Neuron 51 (2006) 213-225
10. Bolaños C.A., and Nestler E.J. Neurotrophic mechanisms in drug addiction. J. Neuromol. Med. 5 (2004) 69-83
11. Bolaños C.A., Perrotti L.I., Edwards S., Eisch A.J., Barrot M., Olson V.G., Russell D.S., Neve R.L., and Nestler E.J. Viral-mediated expression of phospholipase Cγ in distinct regions of the ventral tegmental area differentially modulates mood-related behaviors. J. Neurosci. 23 (2003) 7569-7576
12. Bolaños C.A., Neve R.L., and Nestler E.J. Phospholipase Cγ in distinct regions of the ventral tegmental area differentially regulates morphine-induced locomotor activity. Synapse 56 (2005) 166-169
13. Bonci A., and Malenka R.C. Properties and plasticity of excitatory synapses on dopaminergic and GABAergic cells in the ventral tegmental area. J. Neurosci. 19 (1999) 3723-3730
14. Bramham C.R., and Messaoudi E. BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog. Neurobiol. 76 (2005) 99-125
15. Buckley C.T., and Caldwell K.K. Fear conditioning is associated with altered integration of PLC and ERK signaling in the hippocampus. Pharmacol. Biochem. Behav. 79 (2004) 633-640
16. Carlezon W.A., Boundy V., Haile C., Lane S., Kalb R.G., Neve R., and Nestler E.J. Sensitization to morphine induced by viral-mediated gene transfer. Science 277 (1997) 812-814
17. Chen Y., and Yu L. Differential regulation by cAMP-dependent protein kinase and protein kinase C of the mu opioid receptor coupling to a G protein-activated K+ channel. J. Biol. Chem. 269 (1994) 7839-7842
18. Choi J.H., Park J.B., Bae S.S., Yun S., Kim H.S., Hong W.P., Kim I.S., Kim J.H., Han M.Y., Ryu S.H., Patterson R.L., Snyder S.H., and Suh P.G. Phospholipase C-gamma1 is a guanine nucleotide exchange factor for dynamin-1 and enhances dynamin-1-dependent epidermal growth factor receptor endocytosis. J. Cell Sci. 117 (2004) 3785-3795
19. Diakonova M., Chilov D., Arnaoutov A., Alexeyev V., Nikolsky N., and Medvedeva N. Intracellular distribution of phospholipase C gamma1 in cell lines with different levels of transformation. Eur. J. Cell Biol. 73 (1997) 360-367
20. Duman C.H., Schlesinger L., Kodama M., Russell D.S., and Duman R.S. A role for MAP Kinase signaling in behavioral models of depression and antidepressant treatment. Biol. Psychiatry 61 (2007) 661-670
21. Dwivedi Y., Mondal A.C., Rizavi H.S., Shukla P.K., and Pandey G.N. Single and repeated stress-induced modulation of phospholipase C catalytic activity and expression: role in LH behavior. Neuropsychopharmacology 30 (2005) 473-483
22. Eitan S., Bryant C.D., Saliminejad N., Yang Y.C., Vojdani E., Keith Jr. D., Polakiewicz R., and Evans C.J. Brain region-specific mechanisms for acute morphine-induced mitogen-activated protein kinase modulation and distinct patterns of activation during analgesic tolerance and locomotor sensitization. J. Neurosci. 23 (2003) 8360-8369
23. Freeman A.Y., and Pierce R.C. Neutralization of neutrophin-3 in the ventral tegmental area or nucleus accumbens differentially modulates cocaine-induced behavioral plasticity in rats. Synapse 46 (2002) 57-65
24. Fukuda H., Nishida A., Saito H., Shimizu M., and Yamawaki S. Imipramine stimulates phospholipase C activity in rat brain. Neurochem. Int. 25 (1994) 567-571
25. 2+ release or protein kinase C activation significantly reduces the development of morphine dependence. Eur. J. Pharmacol. 300 (1996) 173-181
26. Gartner A., Polnau D.G., Staiger V., Sciarretta C., Minichiello L., Thoenen H., Bonhoeffer T., and Korte M. Hippocampal long-term potentiation is supported by presynaptic and postsynaptic tyrosine receptor kinase B-mediated phospholipase Cgamma signaling. J. Neurosci. 26 (2006) 3496-3504
27. Ghosh A., and Greenberg M.E. Calcium signaling in neurons: molecular mechanisms and cellular consequences. Science 268 (1995) 239-247
28. Hall F.S., Drgonova J., Goeb M.K., and Uhl G.R. Reduced behavioral effects of cocaine in heterozygous brain-derived neurotrophic factor (BDNF) knockout mice. Neuropsychopharmacology 28 (2003) 1485-1490
29. Harrison J.M., Allen R.G., Pellegrino M.J., Williams J.T., and Manzoni O.J. Chronic morphine treatment alters endogenous opioid control of hippocampal mossy fiber synaptic transmission. J. Neurophysiol. 87 (2002) 2464-2470
30. Horger B.A., Iyasere C.A., Berhow M.T., Messer C.J., Nestler E.J., and Taylor J.R. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J. Neurosci. 19 (1999) 4110-4122
31. Huang E.J., and Reichardt L.F. Trk receptors: roles in neuronal signal transduction. Ann. Rev. Biochem. 72 (2003) 609-642
32. Impey S., Obrietan K., and Storm D.R. Making new connections: role of ERK/MAP kinase signaling in neuronal plasticity. Neuron 23 (1999) 11-14
33. Janak P.H., Wolf F.W., Heberlein U., Pandey S.C., Logrip M.L., and Ron D. BIG news in alcohol addiction: new findings on growth factor pathways BDNF, insulin, and GDNF. Alcohol Clin. Exp. Res. 30 (2006) 214-221
34. Ji Q., Winnier G., Niswender K., Horstman D., Wisdom R., Magnuson M., and Carpenter G. Essential role of the tyrosine kinase substrate phospholipase C-gamma1 in mammalian growth and development. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 2999-3003
35. Jin W., and Chavkin C. Mu opioids enhance mossy fiber synaptic transmission indirectly by reducing GABAB receptor activation. Brain Res. 821 (1999) 286-293
36. Jordan B.A., Trapaidze N., Gomes I., Nivarthi R., and Devi L.A. Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 343-348
37. Katsura M., Ohkuma S., Chen D., and Kuriyama K. Ethanol-induced alteration in activities of cerebral phosphatidlyinositol-4,5-bisphosphate-specific and cytosolic phospholipase C in the brain: analysis using NG 108-15 cells and brains from ethanol inhaled mice. Neurochem. Int. 24 (1994) 541-547
38. Kim H., Kim J., Zilberstein A., Margolis B., Kim J., Schlessinger J., and Rhee S.G. PDGF stimulation of inositol phospholipid hydrolysis requires PLC-gamma1 phosphorylation on tyrosine residues 783 and 1254. Cell 65 (1991) 435-441
39. Kojima N., Wang J., Mansuy I.M., Grant S.G., Mayford M., and Kandel E.R. Rescuing impairment of long-term potentiation in Fyn-deficient mice by introducing Fyn transgene. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 4761-4765
40. Kolch W., Heldecker G., Kochs G., Hummel R., Vahidi H., Mischak H., Finkenzeller G., Marmé D., and Rapp U.F. Protein kinase C alpha activates Raf-1 by direct phosphorylation. Nature 364 (1993) 249-252
41. Kombien S.B., and Malenka R.C. Simultaneous LTP of non-NMDA- and LTD of NMDA-receptor-mediated responses in the nucleus accumbens. Nature 368 (1994) 242-246
42. Koob G.F., Sanna P.P., and Bloom F.E. Neuroscience of addiction. Neuron 21 (1998) 467-476
43. Kozak A., and Yavin E. Isolation and characterization by cell density adjustment of a PC12 pheochromocytoma variant with altered Ca2+ homeostasis. J. Mol. Neurosci. 3 (1992) 203-212
44. Lee Y., Ryu S., Suh P., Park J., Ahn Y., and Kim Y. Tyrosine phosphorylation of PLC-gamma1 induced by electroconvulsive shock in the rat hippocampus. Biochem. Biophys. Res. Comm. 194 (1993) 665-669
45. Lee R.H., Wong W.L., Chan C.H., and Chan S.Y. Differential effects of glial cell line-derived neurotrophic factor and neurturin in RET/GFRalpha1-expressing cells. J. Neurosci. Res. 83 (2006) 80-90
46. Lovlie R., Berle J.O., Stordal E., and Steen V.M. The phospholipase C-gamma1 gene (PLCG1) and lithium-responsive bipolar disorder: re-examination of an intronic dinucleotide repeat polymorphism. Psychiatr. Genet. 11 (2001) 41-43
47. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
48. Lu L., Dempsey J., Liu S.Y., Bossert J.M., and Shaham Y. A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal. J. Neurosci. 24 (2004) 1604-1611
49. Luttrell L.M. Composition and function of G protein-coupled receptor signalsomes controlling mitogen-activated protein kinase activity. J. Mol. Neurosci. 26 (2005) 253-264
50. Maloney J.A., Tsygankova O.M., Yang L., Li Q., Szot A., Baysal K., and Williamson J.R. Activation of ERK by Ca2+ store depletion in rat liver epithelial cells. Am. J. Physiol. 276 (1999) C221-C230
51. Mariappan M.M., Senthil D., Natarajan K.S., Choudhury G.G., and Kasinath B.S. Phospholipase Cgamma-Erk axis in vascular endothelial growth factor-induced eukaryotic initiation factor 4E phosphorylation and protein synthesis in renal epithelial cells. J. Biol. Chem. 280 (2005) 28402-28411
52. Matsumoto T., Numakawa T., Yokomaku D., Adachi N., Yamagishi S., Numakawa Y., Kunugi H., and Taguchi T. Brain-derived neurotrophic factor-induced potentiation of glutamate and GABA release: different dependency on signaling pathways and neuronal activity. Mol. Cell. Neurosci. 31 (2006) 70-84
53. McBride W.J., Murphy J.M., and Ikemoto S. Localization of brain reinforcement mechanisms: intracranial self-administration and intracranical place-conditioning studies. Behav. Brain Res. 101 (1999) 129-152
54. Messer C.J., Eisch A., Carlezon W.A., Whisler K., Shen L., Wolf D.H., Westphal H., Collins F., Russell D.S., and Nestler E.J. Role for GDNF in biochemical and behavioral adaptations to drugs of abuse. Neuron 26 (2000) 247-257
55. Minichiello L., Calella A.M., Medina D.L., Bonhoeffer T., Klein R., and Korte M. Mechanism of TrkB-mediated hippocampal long-term potentiation. Neuron 36 (2002) 121-137
56. Mueller D., Chapman C.A., and Stewart J. Amphetamine induces dendritic growth in ventral tegmental area dopaminergic neurons in vivo via basic fibroblast growth factor. Neuroscience 137 (2006) 727-735
57. Narita M., Narita M., Mizoguchi H., and Tseng L.F. Inhibition of protein kinase C, but not of protein kinase A, blocks the development of acute antinociceptive tolerance to an intrathecally administered mu-opioid receptor agonist in the mouse. Eur. J. Pharmacol. 280 (1995) R1-R3
58. Narita M., Ohnishi O., Narita M., Aoki T., Suzuki M., Yajima Y., Funahashi H., Shioda S., and Suzuki T. Direct evidence for the activation of phospholipase C gamma 1 by in vivo treatment with morphine in the mouse periaqueductal gray matter. Brain Res. 970 (2003) 140-148
59. Nawa H., Saito M., and Nagano T. Neurotrophic factors in brain synaptic plasticity. Crit. Rev. Neurobiol. 11 (1997) 91-100
60. Nestler E.J. Molecular mechanisms of drug addiction. J. Neurosci. 12 (1992) 2439-2450
61. Nestler E.J., and Aghajanian G.K. Molecular and cellular basis of addiction. Science 278 (1997) 58-63
62. Nestler E.J., and Carlezon W.A. The mesolimbic dopamine reward circuit in depression. Biol. Psychiatry 59 (2006) 1151-1159
63. Nestler E.J., Berhow M.T., and Brodkin E.S. Molecular mechanisms of drug addiction: adaptations in signal transduction pathways. Mol. Psychiatry 1 (1996) 190-199
64. Neve R.L., Howe J.R., Hong S., and Kalb R.G. Introduction of the glutamate receptor subunit 1 into motor neurons in vitro and in vivo using a recombinant herpes simplex virus. Neuroscience 79 (1997) 435-447
65. Nishibe S., Wahl M., Hernandez-Sotomayor S., Tonks N., Rhee S.G., and Carpenter G. Increase of the catalytic activity of phospholipase C-gamma1 by tyrosine phosphorylation. Science 250 (1990) 1253-1256
66. Numan S., Lane-Ladd S.B., Zhang L., Lundgren K.H., Russell D.S., Seroogy K.B., and Nestler E.J. Differential regulation of neurotrophin and trk receptor mRNAs in catecholaminergic nuclei during chronic opiate treatment and withdrawal. J. Neurosci. 18 (1998) 10700-10708
67. Patterson S.L., Abel T., Deuel T.A.S., Martin K.C., Rose J.C., and Kandel E.R. Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron 16 (1996) 1137-1145
68. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 3rd ed. (1997), Academic Press, San Diego
69. Pierce R.C., and Bari A.A. The role of neurotrophic factors in psychostimulant-induced behavioral and neuronal plasticity. Rev. Neurosci. 12 (2001) 95-110
70. Pierce R.C., and Kumaresan V. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?. Neurosci. Biobehav. Rev. 30 (2006) 215-238
71. Pu L., Liu Q.S., and Poo M.M. BDNF-dependent synaptic sensitization in midbrain dopamine neurons after cocaine withdrawal. Nat. Neurosci. 9 (2006) 605-607
72. Rajagopal R., Chen Z.Y., Lee F.S., and Chao M.V. Transactivation of Trk neurotrophin receptors by G-protein-coupled receptor ligands occurs on intracellular membranes. J. Neurosci. 24 (2004) 6650-6658
73. Rasmussen K., Beitner-Johnson D., Krystal J.H., Aghajanian G.K., and Nestler E.J. Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates. J. Neurosci. 10 (1990) 2308-2317
74. Rhee S.G. Regulation of phosphoinositide-specific phospholipase C. Ann. Rev. Biochem. 70 (2001) 281-312
75. Rosen L.B., Ginty D.D., Weber M.J., and Greenberg M.E. Membrane depolarization and calcium influx stimulate MEK and MAP kinase via activation of ras. Neuron 12 (1994) 1207-1221
76. Russell D.S. Neurotrophins: mechanisms of action. Neuroscientist 1 (1995) 3-6
77. Russo S.J., Bolaños C.A., Theobald D.E., DeCarolis N.A., Renthal W.R., Kumar A., Winstanley C.A., Renthal N.E., Wiley M.D., Self D.W., Russell D.S., Neve R.L., Eisch A.J., and Nestler E.J. The IRS2-Akt pathway in midbrain dopaminergic neurons regulates behavioral and cellular responses to opiates. Nat. Neurosci. 10 (2007) 93-99
78. Schulz R., Eisinger D.A., and Wehmeyer A. Opioid control of MAP kinase cascade. Eur. J. Pharmacol. 500 (2004) 487-497
79. Segal R.A. Selectivity in neurotrophin signaling: theme and variations. Annu. Rev. Neurosci. 26 (2003) 299-330
80. Sgambato V., Pages C., Rogard M., Besson M., and Caboche J. Extracellular signal-regulated kinase (ERK) controls immediate early gene induction on corticostriatal stimulation. J. Neurosci. 18 (1998) 8814-8825
81. Soderling T.R., and Derkach V.A. Postsynaptic protein phosphorylation and LTP. Trends Neurosci. 23 (2000) 75-80
82. Svoboda K.R., and Lupica C.R. Opioid inhibition of hippocampal interneurons via modulation of potassium and hyperpolarization-activated cation (Ih) currents. J. Neurosci. 18 (1998) 7084-7098
83. 2, and phosphatase inhibitors activate endothelial cell ERK1/2 MAP-kinase. Microvasc. Res. 69 (2005) 36-44
84. Thomas G.M., and Huganir R.L. MAPK cascade signalling and synaptic plasticity. Nat. Rev., Neurosci. 5 (2004) 173-183
85. Valjent E., Pascoli V., Svenningsson P., Paul S., Enslen H., Corvol J.C., Stipanovich A., Caboche J., Lombroso P.J., Nairn A.C., Greengard P., Herve D., and Girault J.A. Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 491-496
86. Wahl M.I., Jones G.A., Nishibe S., Rhee S.G., and Carpenter G. Growth factor stimulation of phospholipase C-gamma1 activity. J. Biol. Chem. 267 (1992) 10447-10456
87. Widmer H., Knusel B., and Hefti F. Stimulation of phosphatidylinositol hydrolysis by brain-derived neurotrophic factor and neurotrophin-3 in rat cerebral cortical neurons developing in culture. J. Neurochem. 59 (1992) 2113-2124
88. Wolf D.H., Numan S., Nestler E.J., and Russell D.S. Regulation of phospholipase Cgamma in the mesolimbic dopamine system by chronic morphine administration. J. Neurochem. 73 (1999) 1520-1528
89. Xia Z., Dudek H., Miranti C.K., and Greenberg M.E. Calcium influx via the NMDA receptor induces immediate early gene transcription by a MAP kinase/ERK-dependent mechanism. J. Neurosci. 16 (1996) 5425-5436
90. Xie W., Samorski G.M., McLaughlin J.P., Romoser V.A., Smrcka A., Hinkle P.M., Bidlack J.M., Gross R.A., Jiang H., and Wu D. Genetic alteration of phospholipase beta3 expression modulates behavioral and cellular responses to mu opioids. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 10385-10390
91. Zhang X., Chattopadhyay A., Ji Q., Owen J.D., Ruest P.J., Carpenter G., and Hanks S.K. Focal adhesion kinase promotes phospholipase C-gamma1 activity. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 9021-9026
92. Zhang W., Trible R.P., Zhu M., Liu S.K., McGlade C.J., and Samelson L.E. Association of Grb2, Gads, and phospholipase C-gamma 1 with phosphorylated LA tyrosine residues. Effect of LAT tyrosine mutations on T cell antigen receptor-mediated signaling. J. Biol. Chem. 275 (2000) 23355-23361
93. Zirrgiebel U., Ohga Y., Carter B., Berninger B., Inagaki N., Thoenen H., and Lindholm D. Characterization of TrkB receptor-mediated signaling pathways in rat cerebellar granule neurons: involvement of protein kinase C in neuronal survival. J. Neurochem. 65 (1995) 2241-2250